Cargando…

Azathioprine, Mercaptopurine, and 5-Aminosalicylic Acid Affect the Growth of IBD-Associated Campylobacter Species and Other Enteric Microbes

Campylobacter concisus is a bacterium that is associated with inflammatory bowel disease (IBD). Immunosuppressive drugs including azathioprine (AZA) and mercaptopurine (MP), and anti-inflammatory drug such as 5-aminosalicylic acid (5-ASA) are commonly used to treat patients with IBD. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fang, Ma, Rena, Riordan, Stephen M., Grimm, Michael C., Liu, Lu, Wang, Yiming, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372805/ https://www.ncbi.nlm.nih.gov/pubmed/28424670 http://dx.doi.org/10.3389/fmicb.2017.00527

Ejemplares similares

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing
por: Broekman, Mark M. T. J., et al.
Publicado: (2017)

The Clinical Importance of Campylobacter concisus and Other Human Hosted Campylobacter Species
por: Liu, Fang, et al.
Publicado: (2018)

Harmful Effects of the Azathioprine Metabolite 6-Mercaptopurine in Vascular Cells: Induction of Mineralization
por: Prüfer, Jasmin, et al.
Publicado: (2014)

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)

New Genetic Biomarkers Predicting Azathioprine Blood Concentrations in Combination Therapy with 5-Aminosalicylic Acid
por: Uchiyama, Kazuhiko, et al.
Publicado: (2014)

Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study
por: Alsous, Mervat M., et al.
Publicado: (2020)

Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine
por: Lambert-Fliszar, Francisca, et al.
Publicado: (2021)

Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation
por: dos Santos, Lana Claudinez, et al.
Publicado: (2015)

Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability
por: Yan, Yuqing, et al.
Publicado: (2023)

Campylobacter concisus Genomospecies 2 Is Better Adapted to the Human Gastrointestinal Tract as Compared with Campylobacter concisus Genomospecies 1
por: Wang, Yiming, et al.
Publicado: (2017)

Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease
por: Yi, Geum-Chae-Won, et al.
Publicado: (2012)

Prevalence of Campylobacter Species in Adult Crohn's Disease and the Preferential Colonization Sites of Campylobacter Species in the Human Intestine
por: Mahendran, Vikneswari, et al.
Publicado: (2011)

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn’s disease in the United States
por: Lund, Jennifer L, et al.
Publicado: (2013)

The Growth and Protein Expression of Inflammatory Bowel Disease-Associated Campylobacter concisus Is Affected by the Derivatives of the Food Additive Fumaric Acid
por: Ma, Rena, et al.
Publicado: (2018)

Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases
por: Valdez-Acosta, Sarahí, et al.
Publicado: (2023)

Examination of the Anaerobic Growth of Campylobacter concisus Strains
por: Lee, Hoyul, et al.
Publicado: (2014)

The interplay between Campylobacter and Helicobacter species and other gastrointestinal microbiota of commercial broiler chickens
por: Kaakoush, Nadeem O, et al.
Publicado: (2014)

Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study
por: Fraser, Simon DS, et al.
Publicado: (2022)

Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease
por: Ismail, Yazan, et al.
Publicado: (2012)

The Effects of Oral and Enteric Campylobacter concisus Strains on Expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 Cells
por: Ismail, Yazan, et al.
Publicado: (2013)

The Isolation of Aeromonas Species and Other Common Enteric Bacterial Pathogens from Patients with Gastroenteritis in an Australian Population
por: Yuwono, Christopher, et al.
Publicado: (2021)

Para-Aminosalicylic Acid: Pas
Publicado: (1950)

Phase Variation During Host Colonization and Invasion by Campylobacter jejuni and Other Campylobacter Species
por: Cayrou, Caroline, et al.
Publicado: (2021)

The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry
por: Fukuda, Tomohiro, et al.
Publicado: (2017)

Limited Impact of 6-Mercaptopurine on Inflammation-Induced Chemokines Expression Profile in Primary Cultures of Enteric Nervous System
por: Kneusels, Jan, et al.
Publicado: (2021)

Clinical manifestation of Campylobacter enteritis in children
por: Bae, Joon Yeol, et al.
Publicado: (2018)

Examination of 189 Campylobacter Species Isolates from the Global Enteric Multicenter Study
por: Risteen, Riley G., et al.
Publicado: (2020)

Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
por: Mahajan, Ramit, et al.
Publicado: (2022)

ENHANCEMENT OF ANTIBODY SYNTHESIS BY 6-MERCAPTOPURINE
por: Chanmougan, Devendrathan, et al.
Publicado: (1966)

SUPPRESSION OF ALLERGIC UVEITIS BY 6-MERCAPTOPURINE
por: Wirostko, E., et al.
Publicado: (1962)

Design and development of hydrogel nanoparticles for mercaptopurine
por: Senthil, V., et al.
Publicado: (2010)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

p-Aminosalicylic Acid (P.A.S.)
por: Spring, F. S.
Publicado: (1949)

Aminosalicylates and COVID-19: Facts or Coincidences?
por: Magro, Fernando, et al.
Publicado: (2021)

Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis
por: Mukhopadhya, Indrani, et al.
Publicado: (2011)

The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
por: Johnston, H. P., et al.
Publicado: (1985)

Analyses of energy metabolism and stress defence provide insights into Campylobacter concisus growth and pathogenicity
por: Yeow, Melissa, et al.
Publicado: (2020)

Self-Assembling Polymers with p-Aminosalicylate Anions Supported by Encapsulation of p-Aminosalicylate for the Improvement of Drug Content and Release Efficiency
por: Keihankhadiv, Shadi, et al.
Publicado: (2023)

Adipose Mesenchymal Stromal Cell Function Is Not Affected by Methotrexate and Azathioprine
por: Mancheño-Corvo, Pablo, et al.
Publicado: (2013)

Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity
por: Chung, Heung Kit Leslie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jj2i8opp677dq34u8afm9dvq80